Honeywell Q2 Preview: Execution Risks and Spin-Off Costs Loom as Separation Milestones Approach

What happened

Honeywell Technologies faces a messy Q2 due to recent Aerospace and Quantinuum spinoffs, creating near-term uncertainty. The company is now a focused automation and industrial technology company, but segment performance and margin improvement targets remain challenging post-spinoff. Management aims for 21% segment margins in 2026, targeting 24% long-term, but execution risks and spin-off costs cloud the outlook. The DeepValue master report rates HON as a WAIT with conviction 2.5, citing a crowded trade around the Q3 2026 Aerospace separation. At $235, the stock prices in a clean separation and sustained aerospace services demand, but near-term cash quality and margin inflection are unproven. The next 3-6 months hinge on the June 3, 2026 Aerospace Investor Day and Form 10 progress, which must clarify standalone margins, leverage, and normalized free cash flow after $1.9B of 2026 adjustments.

Implication

Investors should remain on the sidelines until the June 3 Investor Day and Form 10 amendments provide concrete standalone financials. The stock trades at 29x P/E and 19.6x EV/EBITDA with limited margin of safety. If the Investor Day confirms a credible normalized cash framework and separation timing, the stock could re-rate, but any delay or margin miss would pressure the multiple. The attractive entry is around $220, offering a better risk/reward.

Thesis delta

The Q2 preview reinforces that the near-term earnings picture is messy and the discount is unlikely to close until separation milestones are delivered. No material shift from the WAIT rating; the thesis remains dependent on the June 3 Investor Day and Form 10 progress.